Iizuka M

No ORCID on file · 4 papers in corpus · active 1998-2026

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 3
  • dysmenorrhea 1
2026
Durable complete remission of pulmonary metastases with bevacizumab plus olaparib maintenance therapy in homologous recombination–deficient gynecologic large-cell neuroendocrine carcinoma: A case report
Gynecologic oncology reports ·doi:10.1016/j.gore.2026.102114

Gynecologic neuroendocrine carcinoma (NEC) is a rare and aggressive malignancy with limited treatment options and poor prognosis. Homologous recombination deficiency (HRD) is an established predictive biomarker for poly(ADP-ribose) polymera…

other 2026
Impact of estetrol and drospirenone combination therapy on alleviation of the pelvic pain of endometriosis: a randomized control trial
F&S reports ·doi:10.1016/j.xfre.2025.12.002

OBJECTIVE: To study the impact of estetrol (E4), a novel native estrogen with selective tissue activity, on endometriosis-associated pelvic pain (EAPP) and global impressions of endometriosis pain. DESIGN: Multicenter, randomized, open-lab…

article 1998
Chemical Assay of Iron in Ovarian Cysts: A New Diagnostic Method to Evaluate Endometriotic Cysts
Gynecologic and obstetric investigation ·doi:10.1159/000009999

CA-125 is abundantly secreted from ovarian endometriotic cysts, but is not specific to endometriosis. In order to develop a new, more specific diagnostic marker for endometriosis, the iron concentrations in various ovarian cysts were assaye…

article 1998
Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis
Human Reproduction ·doi:10.1093/humrep/13.7.1952

Danazol is routinely administered orally to inhibit ovulation and to treat pelvic endometriosis. However, recent evidence suggests that danazol can act directly on endometriotic tissue in vitro to inhibit DNA synthesis and induce apoptosis.…